FDA Obtains Permanent Injunction against Two Drug Manufacturers

The Food and Drug Administration recently announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated, or misbranded drugs.

Both Neilgen, which does business as Unigen Pharmaceuticals Inc. (Unigen), and Advent are contract manufacturers and distributors of more than 25 different unapproved drug products each. The unapproved drug products primarily include prescription cough and cold products. These include, but are not limited to:

  • RE All 12 Suspension;
  • BP Allergy Junior Suspension;
  • PE Tann 20 mg/CP Tann 4 mg Suspension
  • BP New Allergy DM Suspension;
  • D-Tann CT Tablets;
  • B-Vex D Suspension;
  • Histex SR; and
  • Chlorpheniramine Maleate 12 mg/Pseudoephedrine HCl 120 mg LA Tablets.

The unapproved drugs manufactured by these companies have not undergone FDA's drug approval process, so their safety and effectiveness have not been established and the FDA has not reviewed the adequacy and accuracy of the directions for use and warnings on the labeling.

Consumers in possession of any of these products should discontinue using them and discuss FDA-approved treatments with their health care professional. Pharmacists should discontinue dispensing these products.

The defendants signed a consent decree that orders them to destroy their existing drug supply, and prohibits them from commercially manufacturing and distributing any new drugs without FDA's approval.

Download Center

  • The Ultimate Guide to OSHA Recordkeeping

    When it comes to OSHA recordkeeping, there are always questions regarding the requirements and in and outs. This guide is here to help!

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • Online Safety Training Buyer's Guide

    Thinking of getting an online safety training solution at work but not sure how to evaluate different solutions and find the one that's best for your company? Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • SDS Software Buyer's Guide

    Whether this is your first time shopping for online SDS software or you’re upgrading from a legacy solution, this guide is designed for you to use in your search for the safety management solution that works best for you and your company.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Vector Solutions

OH&S Digital Edition

  • OHS Magazine Digital Edition - January February 2022

    January February 2022

    Featuring:

    • FACILITY SAFETY
      Industrial Facility Safety from the Loading Dock to the Plant Interior
    • COMBUSTIBLE DUST
      Tiny Particles: Big Booms
    • OIL & GAS
      Creating a Culture of Safety
    • PPE: HAND PROTECTION
      Innovative, Comfortable Hand Protection Option for Workers
    View This Issue